spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  cardiovascular disease 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 27 Aug 2021
Real-World Data Demonstrate Significant Reduction in Complications and Reinterventions with Medtronic Micra Leadless Pacemaker
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Aug 2021
LQT Therapeutics Announces Closing of US$19M Series A Financing to Advance Lead Compound Through Phase 1 while Advancing Portfolio Assets
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 28 Jul 2021
Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring
Devices Cardiology FDA
 HSMN NewsFeed - 26 Jul 2021
Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 9 Jun 2021
MindMed Announces Chief Executive Officer Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2021
Medtronic Announces CE Mark of Evolut(TM) PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jan 2021
Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
Devices Monitoring Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 11 Jan 2021
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jan 2021
Ultromics receives FDA Clearance for a first-of-kind solution in Echocardiography to help clinicians diagnose disease
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 25 Nov 2020
Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy(TM) (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Nov 2020
Signifier Medical Technologies appoints Alastair Maxwell as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 24 Nov 2020
OMRON Strengthens Engagement with AliveCor with Series E Investment, Reinforces Cross-company Alliance for Remote Cardiovascular Condition Management
Devices Cardiology Monitoring Venture Capital
 HSMN NewsFeed - 16 Oct 2020
Akero Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for Efruxifermin (EFX) in NASH
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Oct 2020
Medtronic Launches Head-to-Head TAVR Study Comparing the Evolut(TM) TAVR Platform Against the Edwards SAPIEN Valve in Small Annulus Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Oct 2020
Signifier Medical Technologies appoints Travis Nieman as Managing Director International
Devices Personnel
 HSMN NewsFeed - 30 Sep 2020
Medtronic to Acquire Avenu Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 25 Sep 2020
Study Reveals Blood-Based Host Response Test Can Accurately Predict Respiratory Viral Infection in Pre-Symptomatic Patients
Diagnostics
 HSMN NewsFeed - 16 Sep 2020
Medtronic TYRX(TM) Absorbable Antibacterial Envelope Is Cost Effective for Patients at Increased Risk of Infections
Devices Cardiology
 HSMN NewsFeed - 16 Sep 2020
Signifier Medical Technologies Closes $10M Series C Funding Round
Devices Venture Capital
 HSMN NewsFeed - 2 Sep 2020
NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Jul 2020
Jardiance(R) meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 22 Jul 2020
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 May 2020
Jeffrey J. Popma, M.D. to Join Medtronic as Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart Businesses
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 29 Apr 2020
Medical Diagnostic Laboratories, L.L.C., Launches Serological Test for Coronavirus Disease 2019 (COVID-19) Antibodies in Human Serum
Diagnostics Product Launch
 HSMN NewsFeed - 28 Apr 2020
InterShunt Technologies Announces Formation and Initial Meeting of its Scientific Advisory Board to Guide Development of its Percutaneous Atrial Shunt Catheter System for Heart Failure
Devices Cardiology Personnel
 HSMN NewsFeed - 27 Apr 2020
Cytosorbents Appoints Dr. Efthymios N. Deliargyris, M.D., As Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 9 Jan 2020
Ionis Appoints Onaiza Cadoret-Manier As Chief Corporate Development and Commercial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 6 Jan 2020
Vascular Graft Solutions Acquires the Intellectual Property Developed by Kipsbay Medical Inc.
Devices Interventional Acquisitions
 HSMN NewsFeed - 12 Dec 2019
European Commission Approves EVENITY(R) (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 Dec 2019
Windtree Therapeutics Completes $26.4 Million Private Placement
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Nov 2019
Ultromics Receives FDA Clearance for its AI-powered Decision Support System, EchoGo Core
Devices Cardiology FDA
 HSMN NewsFeed - 24 Oct 2019
Amgen To Make Repatha(R) (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
Biopharmaceuticals Cardiology Reimbursement
 HSMN NewsFeed - 3 Oct 2019
Tenaya Therapeutics Closes $92 Million Series B Financing
Biopharmaceuticals Cardiology Venture Capital Personnel
 HSMN NewsFeed - 23 Sep 2019
First MitraClip(TM) Procedure Performed Using the All-in-One VersaCross(TM) Transseptal Solution
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Sep 2019
CHMP Issues Positive Opinion to Expand Trulicity(R) (dulaglutide) Label to Include Results from REWIND Cardiovascular Outcomes Trial
Biopharmaceuticals Endocrinology Cardiology Regulatory
 HSMN NewsFeed - 18 Sep 2019
Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2019
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Aug 2019
Daiichi Sankyo, Inc. Appoints Simon King as Chief People Officer across U.S. Divisions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2019
Results of the Pivotal Phase 3 Study of the Bempedoic Acid / Ezetimibe Combination Tablet Published in the European Journal of Preventative Cardiology Demonstrated Significant LDL-C Lowering
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 Jul 2019
MiRus Receives FDA Clearance for Lowest Profile Anterior Cervical Plate System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 23 Jul 2019
Ortho Receives CE Mark for Enhanced VITROS(R) Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure
Diagnostics Cardiology Regulatory
 HSMN NewsFeed - 26 Jun 2019
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 26 Jun 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 17 May 2019
U.S. FDA Approves GATTEX(R) (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 13 May 2019
FDA Grants First Ever Clearance For Six-Lead Personal ECG Device
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 9 May 2019
Varian Acquires CyberHeart
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 1 May 2019
Akero Therapeutics Appoints Life Sciences Investment Banking Veteran Bill White as Chief Financial Officer and Head of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2019
New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events in Adults with No Known Heart Disease
Diagnostics Cardiology
 HSMN NewsFeed - 23 Apr 2019
Akero Therapeutics Appoints Industry Veteran Jane Pritchett Henderson to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2019
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 20 Mar 2019
NGM Bio Appoints Hsiao D. Lieu, M.D. as SVP, Chief Medical Officer and Alex DePaoli, M.D. to New Role of SVP, Chief Translational Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2019
Daiichi Sankyo Europe and Esperion Announce Validation of the Marketing Authorisation Application (MAA) for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Fixed Dose Combination Tablet
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 14 Feb 2019
Boehringer Ingelheim and Lilly announce the CAROLINA(R) cardiovascular outcome trial of Tradjenta(R) met its primary endpoint of non-inferiority compared with glimepiride
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 4 Feb 2019
CHMP Recommends Approval of Praluent(R) (alirocumab) Injection to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 30 Jan 2019
CardioVax Announces Name Change to Abcentra
Biopharmaceuticals
 HSMN NewsFeed - 17 Jan 2019
Johnson & Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke Prevention
Devices Cardiology Monitoring
 HSMN NewsFeed - 3 Jan 2019
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Dec 2018
Vast Therapeutics Announces Series A Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Nov 2018
CMS Grants Outpatient Pass-through Payment to the remedē(R) System for the Treatment of Central Sleep Apnea
Devices Neurology Reimbursement
 HSMN NewsFeed - 30 Oct 2018
U.S. FDA Approves INVOKANA(R) (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 4 Oct 2018
Boehringer Ingelheim and Lilly present full results from EASE Phase III program for empagliflozin as adjunct to insulin in type 1 diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 24 Sep 2018
Boston Scientific Receives U.S. FDA Approval for the Eluvia(TM) Drug-Eluting Vascular Stent System
Devices Interventional FDA
 HSMN NewsFeed - 17 Sep 2018
Livongo Announces First Cellular-Enabled Blood Pressure Monitoring System in U.S.
Devices Cardiology Product Launch
 HSMN NewsFeed - 13 Sep 2018
IFM Therapeutics, LLC Appoints John Leonard, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2018
Biohaven Announces Submission of IND for BHV-3500, Third-Generation, Small Molecule CGRP-Receptor Antagonist for the Treatment of Migraine
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 12 Sep 2018
FDA to Review Supplemental Biologics License Application for Praluent(R) (alirocumab)Injection as Potential Treatment to Reduce Major Adverse Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 5 Sep 2018
Halozyme Names Benjamin Hickey As Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Aug 2018
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
Devices Cardiology
 HSMN NewsFeed - 28 Aug 2018
European Society of Cardiology incorporates iFR technology into updated guidelines for revascularization
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Aug 2018
Prevencio Announces Data Demonstrating HART PAD(TM) Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients
Diagnostics Cardiology
 HSMN NewsFeed - 15 Aug 2018
Medtronic Announces Commercial Launch of the IN.PACT(TM) Admiral(TM) Drug-Coated Balloon in Japan
Devices Interventional Product Launch
 HSMN NewsFeed - 16 Jul 2018
Ortho Clinical Diagnostics Launches New MicroTip Partnership Assays for Diabetes, Cardiac and Renal Testing, In Collaboration with Diazyme Laboratories, Inc.
Diagnostics Product Launch
 HSMN NewsFeed - 3 Jul 2018
Sorrento Acquires the Sofusa(TM) Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics
Biopharmaceuticals Oncology Drug Delivery Acquisitions
 HSMN NewsFeed - 28 Jun 2018
Biohaven Expands Rimegepant Development Program to Include New Prevention of Migraine Phase 3 Trial and Highlights Key Late-Breaking Presentations at American Headache Society (AHS) Annual Scientific Meeting
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2018
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 25 Jun 2018
Akero Therapeutics Closes $65 Million Series A Financing to Advance New Treatments for Serious Metabolic Diseases
Biopharmaceuticals Licensing Venture Capital
 HSMN NewsFeed - 15 Jun 2018
Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons
Devices Interventional FDA
 HSMN NewsFeed - 12 Jun 2018
MicroVention Announces FDA Clearance For Thrombectomy Device
Devices Interventional Neurology FDA
 HSMN NewsFeed - 23 May 2018
ReCor Medical Announces RADIANCE-HTN SOLO Hypertension Study Meets Primary Efficacy Endpoint, Pivotal Study Submission, and New Principal Investigator
Devices Cardiology
 HSMN NewsFeed - 1 May 2018
Regeneron and Sanofi to Lower Net Price of Praluent(R) (alirocumab) Injection in Exchange for Straightforward, More Affordable Patient Access for Express Scripts Patients
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 25 Apr 2018
Lilly and China's NCCD announce collaboration to advance scientific understanding and care for people living with diabetes and cardiovascular disease
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 20 Apr 2018
Women Treated with Hologic's NovaSure(R) Endometrial Ablation System in New Study Reported Higher Amenorrhea Rates than Those Treated with Minerva
Devices Interventional
 HSMN NewsFeed - 12 Apr 2018
FDA Permits Marketing of IDx-DR for Automated Detection of Diabetic Retinopathy in Primary Care
Devices Ophthalmology FDA Product Launch
 HSMN NewsFeed - 6 Apr 2018
Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 26 Mar 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 23 Mar 2018
Amgen Receives Positive CHMP Opinion Recognizing That Repatha(R) (evolocumab) Prevents Heart Attacks And Strokes
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 26 Feb 2018
Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 14 Feb 2018
Galmed Announces ARRIVE Study Data
Biopharmaceuticals
 HSMN NewsFeed - 8 Feb 2018
ZYTIGA(R) (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Jan 2018
MyoKardia Announces Appointment of Cynthia Ladd as General Counsel
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 11 Jan 2018
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 10 Jan 2018
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
Biopharmaceuticals Endocrinology Product Launch
 HSMN NewsFeed - 5 Jan 2018
Genome Medical Launches Genetic Health Programs for Employer Groups
Diagnostics Product Launch
 HSMN NewsFeed - 29 Dec 2017
Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace(R) Cream
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 5 Dec 2017
INVOKANA(R) (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Biopharmaceuticals Nephrology
 HSMN NewsFeed - 1 Dec 2017
Bayer and the Broad Institute of MIT and Harvard Expand Partnership to Advance Drug Discovery Research for Novel Cancer Treatments
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Nov 2017
Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 30 Nov 2017
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
Devices Endocrinology Personnel
 HSMN NewsFeed - 20 Nov 2017
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
Biopharmaceuticals FDA Licensing
 HSMN NewsFeed - 16 Nov 2017
Biohaven Completes Enrollment In The First Of Two Pivotal Phase 3 Clinical Trials Of Rimegepant, A Second Generation Oral CGRP-Receptor Antagonist, For The Acute Treatment Of Migraine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Oct 2017
FDA Approves New 10 mg Dosing for XARELTO(R) (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Oct 2017
Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1]
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Sep 2017
Foresee Pharmaceuticals and TRPharm Announce License and Distribution Agreement
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 15 Sep 2017
Janssen Receives CHMP Positive Opinion for Guselkumab Recommending Approval for the Treatment of Moderate to Severe Plaque Psoriasis in the European Union
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 28 Aug 2017
MedGenome Secures $30 Million Series C Funding Led by Sequoia India and Sofina
Diagnostics Venture Capital
 HSMN NewsFeed - 28 Aug 2017
Philips and HeartFlow Announce Global Collaboration Agreement
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Aug 2017
Regeneron and Sanofi to Present New Analyses from Praluent(R) (alirocumab) Injection Trials at the ESC Congress 2017
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Aug 2017
HeartSciences Announces CE Mark and European Launch of MyoVista(R) High Sensitivity ECG Device
Devices Diagnostics Cardiology Regulatory Product Launch
 HSMN NewsFeed - 8 Aug 2017
AUM Cardiovascular Receives FDA Approval For Revolutionary Diagnostic Heart Device
Devices Cardiology FDA
 HSMN NewsFeed - 4 Aug 2017
Lilly Announces Positive Results for Second Phase 3 Study of Lasmiditan for the Acute Treatment of Migraine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Jul 2017
Foresee Pharmaceuticals Announces CEO Appointment
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2017
FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For Repatha(R) (evolocumab) To Include Data On Reducing Risk Of Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 22 Jun 2017
Biohaven Broadens Senior Leadership Team With Veteran Pharma Executives
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Jun 2017
Protagonist Therapeutics Appoints Five Prime Therapeutics CEO, Lewis T. "Rusty" Williams, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2017
Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 1 May 2017
Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 28 Apr 2017
FDA Approves Radius Health’s TYMLOS(TM) (abaloparatide), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Apr 2017
Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 26 Apr 2017
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Devices Interventional Drug Delivery
 HSMN NewsFeed - 25 Apr 2017
AltheaDx Closes $27 Million Series D Financing
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 25 Apr 2017
Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent(R) (alirocumab) Injection
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 13 Apr 2017
Foresee Pharmaceuticals Announces Key Executive Appointments
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 12 Apr 2017
Biotricity Files for its Second and Final FDA 510(k) to Bring Bioflux Solution to Market
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 5 Apr 2017
Foresee Pharmaceuticals Announces Completion of USD16M Fundraising
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 31 Mar 2017
Corindus Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath(R) GRX System
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Mar 2017
Landmark Outcomes Study Shows that Repatha(R) (evolocumab) Decreases LDL-C to Unprecedented Low Levels and Reduces Risk of Cardiovascular Events with No New Safety Issues
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Mar 2017
New Study Shows Prevencio’s Simple Blood Test Determines Risk of Heart Attack, Stroke, or Cardiovascular Death
Diagnostics Cardiology
 HSMN NewsFeed - 7 Mar 2017
Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 22 Feb 2017
Repatha(R) (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 13 Feb 2017
NICE Guidance Recommends HeartFlow FFRct Analysis to Help Determine Cause of Stable Chest Pain in Patients
Devices Diagnostics Cardiology
 HSMN NewsFeed - 9 Feb 2017
Appeals Court Grants Stay of Permanent Injunction for Praluent(R) (alirocumab) During Appeals Process
Biopharmaceuticals Cardiology Litigation
 HSMN NewsFeed - 3 Feb 2017
Amgen Announces Repatha(R) (Evolocumab) Significantly Reduced The Risk Of Cardiovascular Events In FOURIER Outcomes Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Feb 2017
VisCardia Completes $12.5 Million Series B Financing and Assets Transfer to Develop Proprietary Therapeutic Heart Failure Application and Appoints Michael Mirro M.D. as Director of Medical Affairs
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 18 Jan 2017
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Jan 2017
Insys Therapeutics Announces Retirement of Dr. John N. Kapoor as CEO and Chairman; Appoints Dr. Santosh Vetticaden as Interim CEO and Steven Meyer as Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jan 2017
The Medicines Company Announces Positive Top-Line Results from Day 180 Interim Analysis in Ongoing ORION-1 Phase 2 Study of Inclisiran (formerly, PCSK9si)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Jan 2017
Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent(R) (alirocumab) Injection
Biopharmaceuticals Cardiology Litigation
 HSMN NewsFeed - 12 Dec 2016
Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 29 Nov 2016
Innovent Biologics, Inc. Raises USD $260M in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Nov 2016
Shockwave Medical Raises $45 Million in Series C Financing to Further Advance Novel Lithoplasty Treatment for Calcified Arteries
Devices Interventional Venture Capital
 HSMN NewsFeed - 17 Nov 2016
HeartFlow FFRct Analysis Receives Regulatory Approval in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 14 Nov 2016
Technopath Clinical Diagnostics Launches its First Diagnostic Reagent Product, the i-plaq(TM) Test for Lp-PLA2
Diagnostics Cardiology Product Launch
 HSMN NewsFeed - 8 Nov 2016
The Medicines Company Discontinues Development of MDCO-216, its Investigational Cholesterol Efflux Promoter
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Nov 2016
Boston Scientific Announces Initial U.S. Commercial Performance Of The WATCHMAN(TM) Left Atrial Appendage Closure Device
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 2 Nov 2016
Cardinal Health Announces New Strategic Distribution Agreements to Expand Cordis' Cardiovascular Product Offerings in Asia Pacific
Devices Cardiology Distribution
 HSMN NewsFeed - 1 Nov 2016
Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Oct 2016
AliveCor Unveils Medical Grade Mobile App to Manage Top Risk Factors for Stroke
Devices Cardiology
 HSMN NewsFeed - 25 Oct 2016
GenesisCare Continues to Expand Spanish Cancer Services with Elekta
Devices Oncology
 HSMN NewsFeed - 29 Sep 2016
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Sep 2016
KVK Tech Announces FDA-Approval of Lomaira(TM) (phentermine hydrochloride USP) 8 mg tablets, CIV, A Low-Cost, Low-Dose Phentermine That Can Be Used Up To Three Times Daily for Weight Reduction
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Sep 2016
Galmed Pharmaceuticals Announces the Appointment of Dr. Liat Hayardeny, Ph.D. MBA, as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2016
FDA allows Phrixus’s IND for Carmeseal-MD(TM) (P-188 NF) in Duchenne muscular dystrophy (DMD)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Sep 2016
Medtronic Establishes New Office in Vietnam
Devices
 HSMN NewsFeed - 29 Aug 2016
New Repatha(R) (evolocumab) Analyses Show Efficacy and Safety Across Risk Groups in Results Presented at ESC Congress 2016
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Aug 2016
Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 Aug 2016
Arrowhead Pharmaceuticals Closes $45 Million Private Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Aug 2016
ScinoPharm and CVie Therapeutics Limited to Jointly Develop New Heart Failure Drug
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Jul 2016
Shire Receives Extension of Market Authorization in Europe for Revestive(R) (Teduglutide) for the Treatment of Paediatric Patients with Short Bowel Syndrome (SBS)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Jul 2016
Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 5 Jul 2016
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 29 Jun 2016
FDA Advisory Committee recommends approval of Jardiance(R) (empagliflozin) for cardiovascular indication in 12-11 vote
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 23 Jun 2016
HeartFlow Introduces Next Generation Platform
Devices Personalized Medicine Cardiology Product Launch
 HSMN NewsFeed - 7 Jun 2016
Sanifit Appoints Preston S. Klassen MD, MHS as Chief Medical Officer and Announces new US Subsidiary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2016
Abbott to Acquire St. Jude Medical
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 19 Apr 2016
DalCor Pharmaceuticals Completes $150 Million Financing
Biopharmaceuticals Cardiology Venture Capital Personnel
 HSMN NewsFeed - 28 Mar 2016
Aralez Announces FDA Acceptance of New Drug Application for YOSPRALA(TM)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 15 Mar 2016
CoLucid Pharmaceuticals Announces Election of Alison Lawton to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Mar 2016
Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 14 Mar 2016
Arterys Completes Series A Financing
Devices Radiology Venture Capital
 HSMN NewsFeed - 17 Feb 2016
Impax Receives FDA Approval for Generic Version of Adderall XR(R) (mixed salts of a single-entity amphetamine product) Capsules, CII
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 9 Feb 2016
CorMatrix Cardiovascular Inc. Receives 510(k) Clearance for its Tyke(TM) Implantable Device for Neonate and Infant Cardiac Tissue Repair
Devices Cardiology FDA
 HSMN NewsFeed - 4 Feb 2016
Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-3 Trial Of Repatha(R) (Evolocumab) In Statin-Intolerant Patients With High Cholesterol
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2016
Viacoram(R) now approved in Canada as a new first line treatment in hypertension
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 28 Jan 2016
Boston Scientific and Accenture Develop Data-Driven Digital Health Solution to Help Improve Patient Outcomes and Reduce Cost of Treating Chronic Cardiovascular Conditions
Devices
 HSMN NewsFeed - 22 Jan 2016
Amgen's Repatha(R) (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Jan 2016
Novartis receives two new FDA approvals for Cosentyx(R) (secukinumab) to treat patients with ankylosing spondylitis and psoriatic arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Dec 2015
Dr. Elizabeth Nabel Joins Moderna Therapeutics’ Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2015
Antares Pharma Announces FDA Approval of Sumatriptan Injection USP
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Dec 2015
AltheaDx Completes $30M Series C Financing
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 11 Dec 2015
Cardiorentis' Ularitide Receives FDA Fast Track Designation for the Treatment of Acute Decompensated Heart Failure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 7 Dec 2015
Arterys Partners With GE Healthcare To Launch Transformative Cardiac Medical Imaging Platform
Devices Radiology Cardiology Product Launch
 HSMN NewsFeed - 19 Nov 2015
Fractyl Announces Completion of $57 Million Series C Investment
Devices Endocrinology Venture Capital
 HSMN NewsFeed - 11 Nov 2015
Recardio Secures $3 Million in Series A Financing, Relocates Headquarters to San Francisco
Regenerative Medicine Cardiology Venture Capital
 HSMN NewsFeed - 10 Nov 2015
miRagen Therapeutics Secures $41 million Series C Financing to Advance Two MicroRNA Programs into Clinical Trials
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Nov 2015
Zywie Launches Revolutionary Cardiac Monitoring Solution
Devices Monitoring Cardiology Product Launch
 HSMN NewsFeed - 3 Nov 2015
Debiotech and Fresenius Medical Care Announce Exclusive Partnership for New Home Dialysis Product Development
Devices
 HSMN NewsFeed - 2 Nov 2015
Bristol-Myers Squibb to Acquire Cardioxyl Pharmaceuticals, Inc.
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 27 Oct 2015
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Oct 2015
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Oct 2015
Sorin And Cyberonics Announce Appointment Of Remaining Post-Merger Directors Of Combined Company
Devices Cardiology Neurology Personnel Acquisitions
 HSMN NewsFeed - 5 Oct 2015
Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses
Devices Cardiology
 HSMN NewsFeed - 28 Sep 2015
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in the European Union
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 18 Sep 2015
St. Jude Medical Gains CE Mark for 27mm & 29mm Portico TAVR Valves to Complete a Full Portfolio of Portico Sizing Options for Physicians Treating Patients with Aortic Stenosis
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 16 Sep 2015
Amgen To Acquire Privately-Held Dezima Pharma
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 16 Sep 2015
Espero Pharmaceuticals Announces Exclusive Licensing and Distribution Agreement
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 11 Sep 2015
Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha(TM) (Evolocumab)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 20 Aug 2015
Cyberonics and Sorin Provide Merger Update
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 20 Aug 2015
Jardiance(R) Demonstrated Cardiovascular (CV) Risk Reduction in People with Type 2 Diabetes at High Risk for CV Events
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 10 Aug 2015
Chiasma Expands Management Team with Announcement of Anand Varadan as Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 24 Jul 2015
FDA approves Novartis drug Odomzo(R) (sonidegib) for locally advanced basal cell carcinoma (laBCC), a form of skin cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Jul 2015
Regeneron and Sanofi Announce FDA Approval of Praluent(R) (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 21 Jul 2015
Technology Industry Veteran Phil Mui Joins HeartFlow Product & Engineering Team
Devices Cardiology Personalized Medicine Personnel
 HSMN NewsFeed - 10 Jul 2015
Sorin Group Announces Global Launch of Its Latest Generation of Heating and Cooling Systems at FECECT 2015
Devices Cardiology Product Launch
 HSMN NewsFeed - 19 Jun 2015
Sorin Group Announces European Launch of KORA 250, the World’s Smallest Full Body MRI Conditional Pacing System
Devices Cardiology Radiology Product Launch
 HSMN NewsFeed - 1 Jun 2015
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2015
Dassault Systčmes Announces Commercial Availability of Its First Simulated Human Heart
Devices Cardiology Product Launch
 HSMN NewsFeed - 19 May 2015
Shockwave Medical Announces $40 Million in Funding for Novel Lithoplasty System to Treat Advanced Peripheral, Coronary Vascular and Aortic Valve Disease
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 19 May 2015
Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 May 2015
Sorin And Cyberonics Announce Executive Leadership Team For The New Company Upon Close Of Merger
Devices Neurology Mergers & Acquisitions Personnel
 HSMN NewsFeed - 8 May 2015
Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 5 May 2015
OMEICOS Appoints Dr. Ulrich Dauer as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 19 Mar 2015
Janssen Acquires XO1 Limited
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Feb 2015
Sorin Group Receives Regulatory Approval for New Generation MRI Compatible Pacing System in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 6 Jan 2015
Isis Pharmaceuticals Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Dec 2014
HeartFlow Names New General Counsel to Executive Team
Devices Cardiology Personnel
 HSMN NewsFeed - 18 Dec 2014
The Medicines Company and SciClone Pharmaceuticals Establish Strategic Partnership for Two Cardiovascular Products in China
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 17 Dec 2014
ReFlow Medical Corporation Announces FDA 510(k) Clearance And Initial US Clinical Use Of The SpeX(TM) Shapeable Support Catheter
Devices Interventional FDA
 HSMN NewsFeed - 16 Dec 2014
CVRx(R) Granted Humanitarian Device Exemption Approval from FDA for Barostim neo legacy(TM) Hypertension Therapy Device
Devices Cardiology FDA
 HSMN NewsFeed - 11 Dec 2014
CVRx(R) Granted CE Marking of the Barostim neo System(TM) for Conditional MRI Compatibility
Devices Cardiology Regulatory
 HSMN NewsFeed - 26 Nov 2014
Cardio3 BioSciences Announces the Nomination of Three Co-principal Investigators for its CHART-2 Phase III Clinical Trial of C-Cure(R) for the Treatment of Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 11 Nov 2014
BioCardia(R), Inc. Announces FDA Acceptance of Phase III Clinical Trial Protocol Studying Bone Marrow-Derived Cell Therapy for Heart Failure Patients
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 14 Oct 2014
Capricor Therapeutics Announces Acquisition of Intellectual Property Rights to Family of Natriuretic Peptides From Medtronic, Inc.
Biopharmaceuticals Devices Cardiology Acquisitions
 HSMN NewsFeed - 1 Oct 2014
Cardio3 Biosciences Announces New Business Development Strategy To Broaden Its Product Pipeline
Regenerative Medicine
 HSMN NewsFeed - 25 Sep 2014
ReFlow Medical Corporation Announces CE Mark and Initial Clinical Use of the Wingman35 Crossing Catheter and SpeX(TM) Shapeable Support Catheter
Devices Interventional Regulatory
 HSMN NewsFeed - 25 Sep 2014
LabCorp Announces Agreement to Acquire LipoScience
Diagnostics Personalized Medicine Mergers & Acquisitions
 HSMN NewsFeed - 24 Sep 2014
MediValve, Ltd. Announces Initiation of post-Market Clinical Evaluations of the acWire(TM) Guidewire at Lenox Hill Hospital (New York)
Devices Interventional
 HSMN NewsFeed - 4 Sep 2014
EndoCross Receives CE Mark Approval for the ENABLER-C Coronary Catheter System for the Crossing of Coronary Chronic Total Occlusions
Devices INterventional Cardiology Regulatory
 HSMN NewsFeed - 2 Sep 2014
Sorin Group Announces First World Implant of CROWN PRT(TM) Heart Valve
Devices Cardiology
 HSMN NewsFeed - 28 Aug 2014
Armetheon Completes $7.0 Million Series A Financing
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 31 Jul 2014
Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Jul 2014
Surgeons of the University Hospital Essen Complete World's First Robotic-Assisted Cancer Surgery with Medrobotics' Flex(R) System
Devices Oncology Surgery
 HSMN NewsFeed - 23 Jun 2014
Itamar Medical Ltd. signs strategic marketing and distribution agreement for its EndoPAT(TM) device with premier medical device maker Nihon Kohden Japan
Devices Distribution
 HSMN NewsFeed - 18 Jun 2014
Miraculins Signs Letter of Intent for PreVu(R) Distribution in India With $4 Million USD in Minimum Sales Revenues Projected Over Term
Diagnostics Distribution
 HSMN NewsFeed - 16 Jun 2014
Sunshine Heart Appoints Brian Brown as Senior Vice President of Operations and Technology
Devices Cardiology Personnel
 HSMN NewsFeed - 5 Jun 2014
QT Vascular Announces FDA Clearance of Chocolate PTCA Balloon Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 21 May 2014
Boston Scientific Reports Strong Performance Data For SYNERGY(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2014
Boston Scientific Announces Definitive Agreement To Acquire Interventional Division Of Bayer AG
Devices Interventional Acquisitions
 HSMN NewsFeed - 13 May 2014
Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve(R) 100 Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 May 2014
FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 6 May 2014
FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 May 2014
FDA Approves Inspire(R) Upper Airway Stimulation (UAS) Therapy for Obstructive Sleep Apnea
Devices FDA
 HSMN NewsFeed - 29 Apr 2014
Novartis gains FDA approval for Zykadia(TM), first therapy for patients with ALK+ NSCLC previously treated with the ALK inhibitor crizotinib
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Apr 2014
Sorin Group Receives FDA Approval for the Mitroflow (TM) Aortic Heart Valve with New Phospholipid Reduction Treatment
Devices Cardiology FDA
 HSMN NewsFeed - 8 Apr 2014
AtheroNova Appoints Dr. Randolph M. Johnson as Chief Operating Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 8 Apr 2014
Takeda Responds to Verdict in Diabetes Drug Case
Biopharmaceuticals Endocrinology Litigation
 HSMN NewsFeed - 7 Apr 2014
Merck Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Apr 2014
Ablative Solutions Receives FDA Clearance for the Peregrine System(TM) Infusion Catheter
Devices FDA
 HSMN NewsFeed - 31 Mar 2014
New Global Initiative Aims to Improve Patient Outcomes in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Mar 2014
BEAT BioTherapeutics Appoints Dr. Sam L. Teichman as Chief Medical Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 17 Mar 2014
BioCardia(R) Receives CE Mark for Morph AccessPro(TM) Steerable Introducer
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 Mar 2014
Rosetta Genomics Provides Product Pipeline Update
Diagnostics
 HSMN NewsFeed - 10 Mar 2014
Intra-Cellular Therapies Announces the Appointment of Juan Sanchez, M.D., as Vice President of Corporate Communications and Investor Relations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 6 Mar 2014
Boston Heart Enables Healthcare Providers to Better Identify Near-Term Risk of Heart Attack or Stroke with Launch of an Important Inflammation Marker, Myeloperoxidase (MPO)
Diagnostics Cardiology Product Launch
 HSMN NewsFeed - 4 Mar 2014
SharedClarity Awards First Contracts
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 4 Mar 2014
Contextual Genomics Appoints Chris Wagner as President & CEO
Diagnostics Oncology Cardiology Personnel
 HSMN NewsFeed - 21 Feb 2014
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Feb 2014
Medtronic Announces First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker
Devices Interventional Cardiology Cardiology
 HSMN NewsFeed - 18 Feb 2014
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Feb 2014
Medtronic Launches 'TOTAL Across' Crossing Catheter in Europe
Devices Interventional Product Launch
 HSMN NewsFeed - 13 Feb 2014
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2014
Dan Mitchell Joins ARCA biopharma Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 28 Jan 2014
Nonin Medical Announces United Kingdom and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart(TM) Universal Oximetry System
Devices Monitoring Distribution
 HSMN NewsFeed - 28 Jan 2014
Valiant Captivia Thoracic Stent Graft System From Medtronic Receives FDA Approval for Treating Aortic Dissections
Devices Interventional FDA
 HSMN NewsFeed - 28 Jan 2014
Hanover Portfolio Acquisitions Changes Its Name to Endonovo Therapeutics
Devices Regenerative Medicine
 HSMN NewsFeed - 22 Jan 2014
Medtronic SureScan(R) Pacing Systems First to Be Approved for Full Body MRI Scans Without Positioning Restrictions
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 22 Jan 2014
LipoScience Announces Appointment of Howard Doran as President and Chief Executive Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 17 Jan 2014
Medtronic CoreValve(R) System Obtains Early FDA Approval on Exceptional Clinical Performance
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 15 Jan 2014
Medtronic to Appeal Federal District Court Verdict
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 9 Jan 2014
MicroPort Scientific Corporation and Sorin Group Sign Joint Venture Agreement for Cardiac Rhythm Management Business in China
Devices Cardiology
 HSMN NewsFeed - 7 Jan 2014
Forma Therapeutics Appoints Christopher Dinsmore to Vice President, Medicinal and Computational Chemistry
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
Barostim Therapy(TM) Projected to be Cost-Effective in Treating Resistant Hypertension
Devices Cardiology
 HSMN NewsFeed - 6 Jan 2014
Medtronic Announces Acquisition of TYRX, INC., Developer of Solutions for Surgical Site Infections
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 3 Jan 2014
Iroko’s ZORVOLEX(TM) Now Available
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 31 Dec 2013
Miraculins and Cachet Pharmaceutical Agree to 30-Day Extension on Letter of Intent to Continue Negotiation of Licensing Rights for SCOUT DS(R) Diabetes Test in China
Diagnostics Endocrinology Licensing
 HSMN NewsFeed - 23 Dec 2013
European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Dec 2013
Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Dec 2013
St. Jude Medical Gains CE Mark for 25 mm Portico Transcatheter Aortic Heart Valve
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 10 Dec 2013
Medtronic Announces First Human Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Dec 2013
Sorin Group Launches Intensia Family of ICD and CRT-D Devices Featuring DF-4 High Voltage Connector
Devices Cardiology Regulatory
 HSMN NewsFeed - 5 Dec 2013
Medtronic Announces CE Mark and TGA Listing for the Symplicity Spyral(TM) Multi-Electrode Catheter and Symplicity G3(TM) Generator
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 2 Dec 2013
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 27 Nov 2013
Sorin Group Announces CE Mark Approval and First Implant of KORA 100, a New MRI Compatible Pacing System
Devices Cardiology Regulatory
 HSMN NewsFeed - 25 Nov 2013
Sorin Group Announces CE Mark Approval for the XL Version of the Perceval(TM) Sutureless Aortic Valve
Devices Cardiology Regulatory
 HSMN NewsFeed - 22 Nov 2013
Sorin Group Announces CE Mark Approval and First Implant of the New Solo Smart(TM) Biological Aortic Pericardial Heart Valve
Devices Cardiology Regulatory
 HSMN NewsFeed - 18 Nov 2013
Late Breaking Clinical Trial Results Show Significant Delay in Atrial Fibrillation Disease Progression with Medtronic-Exclusive Pacing Features
Devices Cardiology
 HSMN NewsFeed - 14 Nov 2013
Medtronic to Resume Sales of CoreValve System in Germany
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 14 Nov 2013
Jeffrey Paley, MD, Joins Retrophin Inc.’s Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2013
Sorin Group Announces First European Implant of Mitroflow Valsalva Conduit
Devices Cardiology
 HSMN NewsFeed - 5 Nov 2013
OrSense Receives FDA Clearance for Its Noninvasive Hemoglobin Monitor
Devices Monitoring FDA
 HSMN NewsFeed - 31 Oct 2013
Elixir Medical Announces Excellent 1-Year Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve(R) Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Oct 2013
MyoKardia Appoints Tassos Gianakakos to Chief Executive Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 30 Oct 2013
CVRx Closes $12 Million Additional Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 21 Oct 2013
Medtronic Launches New Device To Remove Coronary Thrombus
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 17 Oct 2013
Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Oct 2013
CardioKinetix Announces First Heart Failure Patients Treated in China With Novel Minimally Invasive Structural Heart Device
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2013
FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries
Devices Interventional FDA
 HSMN NewsFeed - 17 Sep 2013
DiaVacs, Inc. Appoints Orville Kolterman, M.D. As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2013
Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2013
InspireMD Announces New Appointment to the Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 4 Sep 2013
New Data Suggests Abbott's High Sensitive Troponin Test May Help Doctors More Accurately Diagnose Heart Attacks in Women
Diagnostics Cardiology
 HSMN NewsFeed - 29 Aug 2013
ObsEva SA Announces CHF 32 Million Series A Funding From Leading Venture Capital Firms and a License Agreement With Merck Serono
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 26 Aug 2013
Galderma Receives FDA Approval of Mirvaso(R): the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 22 Aug 2013
diaDexus, Inc. Appoints Ralf Schoenbrunner to Senior Vice President, Research and Early Development
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 21 Aug 2013
Ironwood Pharmaceuticals Appoints Dr. Michael Hall as Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2013
Medtronic Advances Healthcare Services and Solutions Strategy with Acquisition of Cardiocom
Devices Mergers & Acquisitions
 HSMN NewsFeed - 12 Aug 2013
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Aug 2013
Hologic Launches New Bone Densitometer Platform for Osteoporosis, Cardiovascular Disease, and Obesity Assessment
Devices Radiology Product Launch
 HSMN NewsFeed - 30 Jul 2013
Sialix Raises $1.0 Million in Second Round of Series B Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 22 Jul 2013
ARCA biopharma Announces Additions to GENETIC-AF Leadership Team
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 15 Jul 2013
GeneNews Announces Management and Board Changes
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 12 Jul 2013
American Association Of Clinical Endocrinologists (AACE) Endorses Measurement Of Low-Density Lipoprotein Particle (LDL-P) Number
Diagnostics Endocrinology
 HSMN NewsFeed - 10 Jul 2013
CryoLife Receives FDA Premarket Approval (PMA) for New Sologrip Minimally Invasive TMR Laser Fiber-Optic Delivery System
Devices Cardiology FDA
 HSMN NewsFeed - 8 Jul 2013
Capricor and Nile Therapeutics Announce Merger Agreement
Regenerative Medicine Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 28 Jun 2013
Toshiba Cardiac Ultrasound Improves Visualization, Diagnostic Accuracy
Devices Cardiology Radiology
 HSMN NewsFeed - 19 Jun 2013
AngioScore Announces Completion of Enrollment in Drug-Coated AngioSculpt(R) Scoring Balloon Catheter First-in-Human Study
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Jun 2013
AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza(R) (saxagliptin)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 18 Jun 2013
Sorin Group Launches REPLY(TM) 200 Family of Pacemakers with Sleep Apnea Monitoring for Better Management of Cardiovascular Co-Morbidities1
Devices Cardiology Product Launch
 HSMN NewsFeed - 14 Jun 2013
Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia(R) SC (abatacept) in China
Biopharmaceuticals
 HSMN NewsFeed - 13 Jun 2013
Cerecor Appoints Federica F. O’Brien as Chief Financial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 24 May 2013
Elixir Medical Corporation Announces Outstanding Two-Year Results from the EXCELLA BD Randomized Clinical Trial for the CE Mark-Approved DESyne(R) BD System with Biodegradable Polymer Coating
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2013
Itamar-Medical Appoints Gilad Glick as CEO; Transitioning from Current Role as Vice President Worldwide Sales and Marketing of Johnson & Johnson’s Cardio Division
Devices Personnel
 HSMN NewsFeed - 17 May 2013
New Study Shows Effect of Neupro(R) (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 16 May 2013
St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 13 May 2013
Sorin Group Announces FDA Approval and U.S. Launch of SMARTVIEW(TM) Remote Monitoring Solution for Patients with Implanted Cardiac Defibrillators
Devices Cardiology FDA Product Launch
 HSMN NewsFeed - 11 May 2013
Landmark Study Demonstrates Lower Rate of Inappropriate Shocks in Patients with Sorin Dual Chamber ICD Devices
Devices Cardiology
 HSMN NewsFeed - 7 May 2013
Corgenix Gains CE Mark for ReLASV(R) Antigen Rapid Test for Diagnosis of Lassa Fever
Diagnostics Regulatory
 HSMN NewsFeed - 29 Apr 2013
Sorin Group Receives Conditional FDA Approval to Conduct IDE Clinical Trial for Perceval (TM) S Sutureless Aortic Valve in the United States
Devices Cardiology FDA
 HSMN NewsFeed - 23 Apr 2013
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
Biopharmaceuticals Devices Drug Delivery Generics FDA
 HSMN NewsFeed - 22 Apr 2013
ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for Gencaro(TM)
Biopharmaceuticals Devices Monitoring Cardiology
 HSMN NewsFeed - 17 Apr 2013
VentriPoint Receives CE Mark for Major Expansion of Its VMST Platform for Right Heart Analysis
Devices Cardiology Regulatory
 HSMN NewsFeed - 9 Apr 2013
CardioGuide System Enables Real-Time Navigation of Left Ventricular Leads During Medtronic CRT Implants
Devices Cardiology Product Launch
 HSMN NewsFeed - 27 Mar 2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
Biopharmaceuticals Generics Drug Delivery FDA
 HSMN NewsFeed - 22 Mar 2013
FDA Approves GE Healthcare's AdreView(TM) (Iobenguane I 123 Injection) for Cardiac Risk Evaluation in Heart Failure Patients
Biopharmaceuticals Cardiology Radiology FDA
 HSMN NewsFeed - 12 Mar 2013
Boston Therapeutics Appoints Peter Sheehan, M.D. as Medical Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2013
St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Mar 2013
Toshiba Launches New Cardiac Ultrasound Systems at ACC
Devices Cardiology
 HSMN NewsFeed - 6 Mar 2013
Symplicity(TM) Renal Denervation System One of First Devices Accepted to Participate in Concurrent Review for Joint FDA Premarket Approval and Medicare National Coverage Determination
Devices Interventional Cardiology Reimbursement FDA
 HSMN NewsFeed - 26 Feb 2013
Vasomedical to Showcase EECP(R) Therapy and BIOX(TM) Products at American College of Cardiology's Annual Scientific Session
Devices Cardiology Monitoring
 HSMN NewsFeed - 26 Feb 2013
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 26 Feb 2013
DecImmune Therapeutics Secures $2.25 Million in Development Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Feb 2013
Intravase(R) Approval Opens Vascular Market for Cytori
Regenerative Medicine FDA
 HSMN NewsFeed - 25 Feb 2013
First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
Devices
 HSMN NewsFeed - 19 Feb 2013
Sorin Group Announces the Acquisition of Alcard
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 12 Feb 2013
Aviir Secures Second $10 Million Financing Tranche; Attracts New Investor Group
Diagnostics Cardiology Venture Capital
 HSMN NewsFeed - 11 Feb 2013
Cardiorentis initiates first-ever acute heart failure Phase III clinical trial designed to assess early treatment on cardiovascular mortality and symptoms
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Feb 2013
Amgen Outlines Long-Term Strategy
Biopharmaceuticals
 HSMN NewsFeed - 5 Feb 2013
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna(TM) (imilecleucel-T) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 30 Jan 2013
MyoKardia Appoints Industry Veteran Jonathan Fox, M.D., Ph.D., as Chief Medical Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 25 Jan 2013
AngioScore Launches New 100 mm Length AngioSculpt(R) Scoring Balloons For Treatment of Peripheral Artery Disease Below The Knee (BTK)
Devices Interventional Product Launch
 HSMN NewsFeed - 24 Jan 2013
Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 8 Jan 2013
AtheroNova Names New Clinical Affairs Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 21 Dec 2012
FDA Approves Gattex(R) (teduglutide [rDNA Origin]) for Injection for the Treatment of Adult Short Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 18 Dec 2012
AtheroNova Names New Chief Medical Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 11 Dec 2012
Diffusion Pharmaceuticals Receives FDA Orphan Designation for TSC, a First-in-Class Drug for the Treatment of Metastatic Brain Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Dec 2012
BG Medicine Obtains CE Mark for CardioSCORE(TM) Test in Europe
Diagnostics Cardiology Regulatory
 HSMN NewsFeed - 10 Dec 2012
Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Dec 2012
Clinical study results using Miracor’s PICSO(R) system show potential to treat severe heart attack (STEMI) patients and are published in December’s Journal of Interventional Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Dec 2012
Sorin Group Receives PMDA Approval and Announces Commercial Launch of the Mitroflow(R) Aortic Pericardial Heart Valve in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 28 Nov 2012
Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development and License Agreement for Temanogrel, a Novel Agent for Thrombotic Diseases
Biopharmaceuticals Licensing Cardiology
 HSMN NewsFeed - 19 Nov 2012
ZYTIGA(R) Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Nov 2012
Nanosphere Receives FDA Clearance to Market Test for Detection of CYP2C19 Mutations Affecting Drug Metabolism
Diagnostics FDA
 HSMN NewsFeed - 12 Nov 2012
Sorin Group Announces the Acquisition of Neurotech, a Development-Stage Company Focused on Neurostimulation
Devices Cardiology Neurology Mergers & Acquisitions
 HSMN NewsFeed - 8 Nov 2012
FDA Grants Diazyme Clearance to Market a New Biomarker for Early Detection of Kidney Disease, on the SMART Point of Care System
Diagnostics FDA
 HSMN NewsFeed - 6 Nov 2012
Sorin Group Announces U.S. Launch of New Heart Device for Simultaneous Implantation of an Aortic Tissue Valve and Ascending Aorta
Devices Cardiology
 HSMN NewsFeed - 24 Oct 2012
Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne(R) System
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Oct 2012
AngioScore Announces Successful Initiation of Enrollment in the Valvuloplasty Scoring Balloon for Critical Aortic Valve Stenosis First-in-Human Study
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Oct 2012
First Patient Treated in Cytori’s U.S. Cell Therapy Heart Failure Trial
Regenerative Medicine Cardiology
 HSMN NewsFeed - 8 Oct 2012
Spectranetics Announces U.S. Launch of the TAPAS(TM) Catheter and Preclinical Animal Data on Drug Uptake in Peripheral Vessels
Devices Interventional Drug Delivery Distribution
 HSMN NewsFeed - 3 Oct 2012
Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement
Biopharmaceuticals
 HSMN NewsFeed - 26 Sep 2012
Merck Returns Global Marketing and Development Rights for Vernakalant to Cardiome
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 Sep 2012
Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease
Personalized Medicine Cardiology Venture Capital
 HSMN NewsFeed - 20 Sep 2012
Seattle Children's Hospital Acquires VentriPoint Heart Analysis System
Diagnostics Cardiology
 HSMN NewsFeed - 18 Sep 2012
Sorin Group Announces CE Mark Approval of Extended Indications and 2nd Generation Accessories for Perceval(TM) S
Devices Cardiology Surgery Regulatory
 HSMN NewsFeed - 13 Sep 2012
Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2012
Sorin Group Receives SFDA Approval and Announces Commercial Launch of REPLY(TM) and ESPRIT(TM) Families of Pacemakers in China
Devices Cardiology Regulatory
 HSMN NewsFeed - 29 Aug 2012
U.S. FDA Grants Priority Review of ZYTIGA(R) (abiraterone acetate) sNDA for Treatment of Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Aug 2012
Elixir Medical Receives CE Mark Approval for the DESyne(R) BD Novolimus Eluting Coronary Stent System With Biodegradable Polymer Coating
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Aug 2012
CardioDx Completes $58 Million Equity Financing
Diagnostics Cardiology Venture Capital
 HSMN NewsFeed - 16 Jul 2012
UCB Launches Neupro(R) in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 10 Jul 2012
Cardiosolutions, Inc. Gathers Major Investment from Sorin Group
Devices Cardiology
 HSMN NewsFeed - 9 Jul 2012
Sorin Group Invests in Cardiosolutions, a Development-Stage Company Focused on Mitral Valve Technology
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Jul 2012
CVRx(R) Names Philippe Wanstok Chief Commercial Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 9 Jul 2012
Delcath Announced Changes To Board Of Directors
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 2 Jul 2012
AngioScore Files Patent Infringement Suit Against TriReme Medical and Quattro
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 27 Jun 2012
Kedem Pharmaceuticals to Appoint New Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2012
Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2012
Dexcom Receives CE Mark Approval for the Dexcom G4(R) Continuous Glucose Monitoring System
Devices Monitoring Endocrinology Regulatory
 HSMN NewsFeed - 13 Jun 2012
Sorin Group and Orange Business Services Launch a Remote Monitoring Solution for Patients with Implanted Cardiac Devices in Europe
Devices Cardiology
 HSMN NewsFeed - 25 May 2012
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
Devices Interventional Cardiology Endocrinology
 HSMN NewsFeed - 16 May 2012
Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2012
Elixir Medical Announces Excellent Results from DESolve I First-In-Man Study for the Fully Bioresorbable Drug Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2012
Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty Ring in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 16 May 2012
Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure
Devices Cardiology
 HSMN NewsFeed - 15 May 2012
CryoLife to Acquire Hemosphere
Devices Mergers & Acquisitions
 HSMN NewsFeed - 15 May 2012
Elixir Medical Announces Continued Excellent One Year Safety and Efficacy Data from the EXCELLA BD Randomized Clinical Trial for DESyne BD(TM) Novolimus Eluting Coronary Stent with Biodegradable Polymer
Devices Interventional Cardiology
 HSMN NewsFeed - 14 May 2012
ReCor Medical Completes REDUCE Pilot Clinical Study of Its PARADISE(TM) Ultrasound Transcatheter Renal Denervation System for Treating Resistant Hypertension
Devices Interventional Cardiology
 HSMN NewsFeed - 11 May 2012
New Data from Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving CRT-D Therapy in Mildly Symptomatic Heart Failure Patients
Devices Cardiology
 HSMN NewsFeed - 10 May 2012
Sorin Group Announces FDA Approval and Commercial Launch of Complete Portfolio of Implantable Heart Device Leads
Devices Cardiology FDA
 HSMN NewsFeed - 9 May 2012
Heartbeat International and BIOTRONIK Expand Fight Against Cardiovascular Disease in Mexico
Devices Cardiology
 HSMN NewsFeed - 7 May 2012
Maria Sainz Joins CardioKinetix as President and Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 27 Apr 2012
Trial of Medtronic Symplicity(TM) Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Apr 2012
miRagen Therapeutics Secures $20 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Apr 2012
Medtronic Announces Global Drug-Eluting Balloon Study
Devices Interventional
 HSMN NewsFeed - 16 Apr 2012
Medtronic Endurant(R) AAA Stent Graft Shows Durable Performance at Two Years in U.S. Study
Devices Interventional
 HSMN NewsFeed - 13 Apr 2012
Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study
Devices Interventional
 HSMN NewsFeed - 11 Apr 2012
Takeda to Acquire URL Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Apr 2012
TONIX Pharmaceuticals Strengthens Management Team with the Appointments of Its New Chief Financial Officer and Senior Director of Drug Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 Apr 2012
Neupro(R) Approved by U.S. FDA for Parkinson’s Disease and Restless Legs Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 26 Mar 2012
CorMatrix Adds John Davis as Executive Vice President of Sales and Marketing
Devices Cardiology Regenerative Medicine Personnel
 HSMN NewsFeed - 22 Mar 2012
POZEN Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of PA32540
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 21 Mar 2012
Seattle Genetics Appoints Dr. Nancy Simonian to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Mar 2012
FDA Grants Cytori 510(k) Clearance for Puregraft(R) 850
Devices FDA
 HSMN NewsFeed - 14 Mar 2012
Aastrom Biosciences Appoints Dr. LaVonne Lang as Head of Regulatory Affairs
Regenerative Medicine Personnel
 HSMN NewsFeed - 14 Mar 2012
Everist Genomics Develops World's First Comprehensive Companion Diagnostics and Prognostics Portfolio for Early Diagnosis and Improved Treatment of Colorectal Cancer
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 5 Mar 2012
diaDexus Launches PLAC(R) Test for Lp-PLA(2) Activity in Europe
Diagnostics Cardiology
 HSMN NewsFeed - 1 Mar 2012
Allegheny General Hospital Implants Region's First SynCardia Total Artificial Heart
Devices Cardiology
 HSMN NewsFeed - 23 Feb 2012
ULURU Inc. Announces Approval to Market Altrazeal(R) in Australia
Biopharmaceuticals Wound Care Regulatory
 HSMN NewsFeed - 21 Feb 2012
Sorin Group Announces First Implant in U.S. Study of Stentless Pericardial Aortic Valve
Devices Cardiology
 HSMN NewsFeed - 20 Feb 2012
ReCor Medical Announces CE Mark Approval for Its Novel PARADISE(TM) Ultrasound Transcatheter Renal Denervation System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 Feb 2012
Miraculins Appoints Distinguished U.S. Cardiologist Dr. Henry Solomon to PreVu Medical Advisory Board
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 14 Feb 2012
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Regenerative Medicine Cardiology
 HSMN NewsFeed - 13 Feb 2012
Medtronic Launches Two New Clinical Programs to Evaluate the Use of Symplicity(TM) 1 Renal Denervation System across Multiple Conditions
Devices Cardiology
 HSMN NewsFeed - 31 Jan 2012
Sorin Group Launches a New Complete Portfolio of Pacing, Defibrillation and Left Ventricular Leads
Devices Cardiology Regulatory
 HSMN NewsFeed - 27 Jan 2012
Sorin Group Opens New International Training Center for Healthcare Professionals
Devices
 HSMN NewsFeed - 25 Jan 2012
New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes Results From the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 24 Jan 2012
First Patient Enrolled in Medtronic-Supported Head-to-Head Clinical Trial Comparing Cryoballoon Ablation to RF Ablation for Paroxysmal Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 18 Jan 2012
diaDexus, Inc. Names Jean-Frederic Viret, Ph.D. Chief Financial Officer
Diagnostics Personnel
 HSMN NewsFeed - 10 Jan 2012
Shire Acquires US Rights to Resolor(R) (prucalopride)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Jan 2012
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies for Once-Daily Relovair(TM)* in COPD and Asthma
Biopharmaceuticals
 HSMN NewsFeed - 3 Jan 2012
New Study Links Daily Aspirin Use to Increased Risk of Age-Related Macular Degeneration
Biopharmaceuticals Cardiology Ophthalmology
 HSMN NewsFeed - 3 Jan 2012
Novadaq Names MAQUET Cardiovascular Exclusive U.S. Distributor of CO2 Heart Laser Products
Devices Cardiology Distribution
 HSMN NewsFeed - 14 Dec 2011
AngioScore Announces Successful Initiation of Enrollment in Drug-Coated AngioSculpt(R) Scoring Balloon Catheter First-in-Human Study
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Dec 2011
Merck Establishes New MSD R&D Asia Headquarters
Biopharmaceuticals
 HSMN NewsFeed - 25 Nov 2011
Amarin Announces Resignation of David Feigal from Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2011
Athersys Announces Recovery of All Rights to Cardiovascular Cell Therapy Program
Regenerative Medicine Cardiology
 HSMN NewsFeed - 7 Nov 2011
Vascular Dynamics Names Former Micrus Endovascular President Robert Stern as President and CEO
Devices Personnel
 HSMN NewsFeed - 4 Nov 2011
Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Nov 2011
Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance(R) Drug Eluting Balloon with Paccocath(R) Technology to be Presented at 2011 TCT
Devices Interventional
 HSMN NewsFeed - 1 Nov 2011
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Oct 2011
Sarah Schiltz Named VP of Marketing at Atherotech Diagnostics Lab
Diagnostics Personnel
 HSMN NewsFeed - 26 Oct 2011
St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System
Devices Cardiology FDA
 HSMN NewsFeed - 17 Oct 2011
St. Jude Medical Announces First Use of Renal Denervation Technology
Devices
 HSMN NewsFeed - 17 Oct 2011
Sorin Group Invests in Enopace Biomedical, Early Stage Company Focused on Innovative Solution for Heart Failure Patients
Devices Cardiology
 HSMN NewsFeed - 12 Oct 2011
Sorin Group Launches SonR(R) Sensor Based Cardiac Resynchronization Therapy (CRT) Optimization System (1)
Devices Cardiology
 HSMN NewsFeed - 10 Oct 2011
Medtronic Announces Results from TTOP-AF Trial Demonstrating Clinical Benefits of Its Phased RF Ablation System in Treating Persistent Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 30 Sep 2011
National Healing Corporation and Diversified Clinical Services to Merge
Devices Wound Care Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2011
NPS Pharmaceuticals Appoints Eric Pauwels as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2011
Vasomedical Announces Corporate Restructure and Appointment of New Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 13 Sep 2011
John Sperzel Appointed as Chief Executive Officer of ITC Nexus Dx
Diagnostics Personnel
 HSMN NewsFeed - 7 Sep 2011
MiCardia Corporation Receives CE Mark for the enCorSQ Mitral Valve Repair SystemTM
Devices Cardiology Regulatory
 HSMN NewsFeed - 6 Sep 2011
AngioScore Launches New 100 mm AngioSculpt(R) Scoring Balloon Catheters for Treatment of Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 31 Aug 2011
St. Jude Medical Begins U.S. Trial Studying ST Segment Monitoring Technology
Devices Cardiology Monitoring
 HSMN NewsFeed - 31 Aug 2011
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Aug 2011
Study Shows Medtronic CoreValve(R) System Efficacy and Durability Through Four Years in Longest-Term Industry Data Available
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Aug 2011
Vasomedical Announces Agreement to Acquire Two China-based Companies
Devices Mergers & Acquisitions
 HSMN NewsFeed - 17 Aug 2011
OPKO Invests in Cardiac Device Company
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Aug 2011
Daiichi Sankyo, Inc. Appoints Executive Vice President of Drug Development for the Americas
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Aug 2011
Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Aug 2011
Medtronic Receives FDA Approval for Advisa DR MRI(TM) SureScan(R) Pacing System Clinical Trial
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 28 Jul 2011
Ramona M. Lloyd, Ph.D., RAC, Joins Omthera Pharmaceuticals as Vice President Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2011
Sorin Group Receives CE Mark Approval for the Mitroflow Aortic Pericardial Heart Valve with Phospholipid Reduction Treatment
Devices Cardiology Regulatory
 HSMN NewsFeed - 28 Jul 2011
Genzyme and Isis Announce Submission of European Marketing Authorization Application for Mipomersen (Kynamro(R))
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Jul 2011
Diffusion Pharmaceuticals Receives FDA Orphan Status for TSC, a First-in-Class Drug for the Treatment of Primary Brain Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Jul 2011
Bristol-Myers Squibb to Acquire Amira Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Jul 2011
Sorin Group Announces Purchase of Estech Cannulae Product Line
Devices Cardiology Acquisitions
 HSMN NewsFeed - 14 Jul 2011
St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jul 2011
POZEN Announces Tomas S. Bocanegra, M.D. as Head of Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jul 2011
Zafgen Secures $33 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jul 2011
Vasomedical Receives FDA 510(k) Clearance on Two Additional BIOX(TM) Monitors
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 27 Jun 2011
SciFluor Life Sciences Appoints Life Sciences Executive Arthur Hiller as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jun 2011
Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Jun 2011
Cyterix Pharmaceuticals Raises $9.2 Million in a Series A Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jun 2011
XOMA Appoints Paul Rubin, M.D. as Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2011
Sorin Group Announces First North American Implant of the Freedom Solo Pericardial Aortic Valve
Devices Cardiology
 HSMN NewsFeed - 23 May 2011
Elixir Medical Receives CE Mark for DESyne(TM) Novolimus Eluting Coronary Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 May 2011
ELIQUIS(R) (apixaban) Approved In Europe For Preventing Venous Thromboembolism After Elective Hip Or Knee Replacement
Biopharmaceuticals Surgery Orthopaedic
 HSMN NewsFeed - 19 May 2011
MEDRAD Launches Second Generation Intego PET Infusion System
Devices Radiology Oncology
 HSMN NewsFeed - 18 May 2011
Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 3 May 2011
EBR Systems Announces First Human Implants of the WiCS(R) Wireless Cardiac Stimulation System
Devices Cardiology
 HSMN NewsFeed - 2 May 2011
Sorin Group Launches the VascuClear(TM) Endoscopic Vessel Harvesting System
Devices Interventional
 HSMN NewsFeed - 29 Apr 2011
Sorin Group Announces U.S. Launch of XTRA(R) Autotransfusion System
Devices Surgery
 HSMN NewsFeed - 27 Apr 2011
PhaseBio Pharmaceuticals, Inc. Announces the Appointment of Kathryn J. Gregory Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2011
Horizon Pharma Announces FDA Approval of DUEXIS(R) (ibuprofen/famotidine) for the Relief of the Signs and Symptoms of Rheumatoid Arthritis and Osteoarthritis and to Decrease the Risk of Developing Upper Gastrointestinal Ulcers
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Apr 2011
Preliminary Injunction Ordered in POZEN Treximet Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Apr 2011
Portola Pharmaceuticals Appoints Dr. James Topper to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2011
NewCardio Study Shows my3KG Improves Diagnostic Accuracy in Diabetics With Acute Myocardial Infarction
Devices Diagnostics Cardiology Endocrinology
 HSMN NewsFeed - 5 Apr 2011
Toshiba Introduces Enhancements on Its Ultrasound Product Line to Improve Cardiac Diagnostic Capabilities
Devices Cardiology
 HSMN NewsFeed - 4 Apr 2011
SCAI Statement on "The RIVAL Trial: A Randomized Comparison of Radial Versus Femoral Access for Coronary Angiography or Intervention in Patients With Acute Coronary Syndromes"
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Apr 2011
Medtronic Resolute(R) Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Apr 2011
Harvard Clinical Research Institute and Saint Luke’s Mid America Heart and Vascular Institute Complete Cost-Effectiveness Analysis for SAPIEN Transcatheter Heart Valve
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Apr 2011
Tobira Therapeutics Appoints Andrew Hindman President and Chief Executive Officer
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 1 Apr 2011
AngioScore Launches New Longer AngioSculpt(R) Devices for Treatment of Peripheral Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 29 Mar 2011
Breaking ICU Study: New, Noninvasive Alternative in Aortic Pressure Monitoring
Devices Cardiology Monitoring
 HSMN NewsFeed - 28 Mar 2011
Medtronic to Unveil Pivotal U.S. Data on Resolute(R) Drug-Eluting Stent at ACC.11
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2011
Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2011
Medtronic Announces FDA Approval of Consulta(R) and Syncra(TM) Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Systems
Devices Cardiology FDA
 HSMN NewsFeed - 21 Mar 2011
Selventa Names John Tagliamonte as Senior Vice President of Corporate Development
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 18 Mar 2011
Quest Diagnostics to Acquire Celera, Strengthening Position as World's Leading Innovator in Molecular Diagnostics and Development
Diagnostics Personalized Medicine Mergers & Acquisitions
 HSMN NewsFeed - 14 Mar 2011
Omthera Pharmaceuticals Initiates Pivotal Phase III EVOLVE Trial for Epanova in Patients with Very High Triglycerides
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2011
Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding Led by New Enterprise Associates
Biopharmaceuticals Venture Capital
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
cardiovascular disease
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.